TY - T1 - Healthcare professionals’ perspective on improving adverse drug reaction reporting in Finland SN - / UR - URN:NBN:fi:hulib-202111174062; http://hdl.handle.net/10138/336468 T3 - A1 - Salminen, Veera A2 - PB - Helsingin yliopisto Y1 - 2021 LA - eng AB - Continuous monitoring of the safety profile of medicinal products is essential also after marketing authorisation approval to ensure the patient safety. Spontaneous reporting of adverse drug reactions is one of the most important methods to collect post-approval safety data of medicinal products. The advantages of spontaneous reporting system include reaching large population throughout a long period of time for many medicinal products, however, it also has some limitations. One commonly recogni... VO - IS - SP - OP - KW - spontaneous reporting; adverse drug reaction; healthcare professional; under-reporting; improvement; Teollisuusfarmasia; Industrial pharmacy; Industriell farmaci; Proviisorin koulutusohjelma; Master 's Programme in Pharmacy; Utbildningsprogrammet för provisorsexamen N1 - PP - ER -